Screening for amyloid aggregation: In-silico, in-vitro and in-vivo detection

Current Protein and Peptide Science

Volumn 15, Issue 5, 2014, Pages 477-489

  Villar Piqué, Anna ^a   Espargaró, Alba ^b,c   Ventura, Salvador ^a   Sabate, Raimon ^b,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Amyloid; Amyloid detection methods; Protein aggregation; Protein folding

Indexed keywords

AMYLOID; THIOFLAVINE; CYTOTOXIN;

AGAR GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; CELL VIABILITY; COMPUTER MODEL; CYTOTOXICITY; EXPERIMENTAL DESIGN; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; INFRARED SPECTROSCOPY; METHODOLOGY; MICROSCOPY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; QUANTITATIVE ASSAY; REVIEW; X RAY DIFFRACTION; YEAST; ANIMAL; CHEMISTRY; COMPUTER SIMULATION; PROTEIN MULTIMERIZATION;

AMYLOID; ANIMALS; COMPUTER SIMULATION; CYTOTOXINS; HUMANS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY;

EID: 84904499277     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/1389203715666140221101038     Document Type: Review

References (189)

1. Byers, A.L.; Yaffe, K. Depression and risk of developing dementia. Nat. Rev. Neurol., 2011, 7(6), 323-331.
2. Porzoor, A.; Macreadie, I.G. Application of Yeast to Study the Tau and Amyloid-beta Abnormalities of Alzheimer's Disease. J. Alzheimers Dis., 2013, 35(2), 217-225.
3. Reitz, C.; Brayne, C.; Mayeux, R. Epidemiology of Alzheimer disease. Nat. Rev. Neurol., 2011, 7(3), 137-152.
4. Pedersen, J.S.; Dikov, D.; Flink, J.L.; Hjuler, H.A.; Christiansen, G.; Otzen, D.E. The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. J. Mol. Biol., 2006, 355(3), 501-523.
5. Sabate, R.; Baxa, U.; Benkemoun, L.; Sanchez de Groot, N.; Coulary-Salin, B.; Maddelein, M.L.; Malato, L.; Ventura, S.; Steven, A.C.; Saupe, S.J. Prion and non-prion amyloids of the HET-s prion forming domain. J. Mol. Biol., 2007, 370(4), 768-783.
6. Tanaka, M.; Chien, P.; Naber, N.; Cooke, R.; Weissman, J.S. Conformational variations in an infectious protein determine prion strain differences. Nature, 2004, 428(6980), 323-328.
7. Tanaka, M.; Collins, S.R.; Toyama, B.H.; Weissman, J.S. The physical basis of how prion conformations determine strain phenotypes. Nature, 2006, 442(7102), 585-589.
8. Lopez de la Paz, M.; Serrano, L. Sequence determinants of amyloid fibril formation. Proc. Natl. Acad. Sci. U S A., 2004, 101(1), 87-92.
9. Sanchez de Groot, N.; Pallares, I.; Aviles, F.X.; Vendrell, J.; Ventura, S. Prediction of hot spots of aggregation in diseaselinked polypeptides. BMC Struct. Biol., 2005, 5, 18.
10. Esteras-Chopo, A.; Serrano, L.; Lopez de la Paz, M. The amyloid stretch hypothesis: recruiting proteins toward the dark side. Proc. Natl. Acad. Sci. U S A., 2005, 102(46), 16672-16677.
11. Ivanova, M.I.; Sawaya, M.R.; Gingery, M.; Attinger, A.; Eisenberg, D. An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. Proc. Natl. Acad. Sci. U S A., 2004, 101(29), 10584-10589.
12. Monsellier, E.; Ramazzotti, M.; Taddei, N.; Chiti, F. Aggregation propensity of the human proteome. PLoS Comput. Biol., 2008, 4(10), e1000199.
13. Rousseau, F.; Serrano, L.; Schymkowitz, J.W. How evolutionary pressure against protein aggregation shaped chaperone specificity. J. Mol. Biol., 2006, 355(5), 1037-1047.
14. Ventura, S.; Zurdo, J.; Narayanan, S.; Parreno, M.; Mangues, R.; Reif, B.; Chiti, F.; Giannoni, E.; Dobson, C.M.; Aviles, F.X.; Serrano, L. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc. Natl. Acad. Sci. U S A., 2004, 101(19), 7258-7263.
15. Castillo, V.; Grana-Montes, R.; Sabate, R.; Ventura, S. Prediction of the aggregation propensity of proteins from the primary sequence: aggregation properties of proteomes. Biotechnol. J., 2011, 6(6), 674-685.
16. Belli, M.; Ramazzotti, M.; Chiti, F. Prediction of amyloid aggregation in vivo. EMBO Rep., 2011, 12(7), 657-663.
17. Conchillo-Sole, O.; de Groot, N.S.; Aviles, F.X.; Vendrell, J.; Daura, X.; Ventura, S. AGGRESCAN: a server for the prediction and evaluation of hot spots of aggregation in polypeptides. BMC Bioinformatics, 2007, 8, 65.
18. Fernandez-Escamilla, A.M.; Rousseau, F.; Schymkowitz, J.; Serrano, L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol., 2004, 22(10), 1302-1306.
19. Garbuzynskiy, S.O.; Lobanov, M.Y.; Galzitskaya, O.V. FoldAmyloid: a method of prediction of amyloidogenic regions from protein sequence. Bioinformatics, 2010, 26(3), 326-332.
20. Maurer-Stroh, S.; Debulpaep, M.; Kuemmerer, N.; Lopez de la Paz, M.; Martins, I.C.; Reumers, J.; Morris, K.L.; Copland, A.; Serpell, L.; Serrano, L.; Schymkowitz, J.W.; Rousseau, F. Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat. Methods, 2010, 7(3), 237-242.
21. Tartaglia, G.G.; Vendruscolo, M. The Zyggregator method for predicting protein aggregation propensities. Chem. Soc. Rev., 2008, 37(7), 1395-1401.
22. Bryan, A.W., Jr.; Menke, M.; Cowen, L.J.; Lindquist, S.L.; Berger, B. BETASCAN: probable beta-amyloids identified by pairwise probabilistic analysis. PLoS Comput. Biol., 2009, 5(3), e1000333.
23. Yoon, S.; Welsh, W.J.; Jung, H.; Yoo, Y.D. CSSP2: an improved method for predicting contact-dependent secondary structure propensity. Comput. Biol. Chem., 2007, 31(5-6), 373-377.
24. Trovato, A.; Seno, F.; Tosatto, S.C. The PASTA server for protein aggregation prediction. Protein Eng. Des. Sel., 2007, 20(10), 521-523.
25. Thompson, M.J.; Sievers, S.A.; Karanicolas, J.; Ivanova, M.I.; Baker, D.; Eisenberg, D. The 3D profile method for identifying fibril-forming segments of proteins. Proc. Natl. Acad. Sci. U S A., 2006, 103(11), 4074-4078.
26. Frousios, K.K.; Iconomidou, V.A.; Karletidi, C.M.; Hamodrakas, S.J. Amyloidogenic determinants are usually not buried. BMC Struct. Biol., 2009, 9(44.
27. Sabate, R.; Espargaro, A.; de Groot, N.S.; Valle-Delgado, J.J.; Fernandez-Busquets, X.; Ventura, S. The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils. J. Mol. Biol., 2010, 404(2), 337-352.
28. Sabate, R.; Lascu, I.; Saupe, S.J. On the binding of Thioflavin-T to HET-s amyloid fibrils assembled at pH 2. J. Struct. Biol., 2008, 162(3), 387-396.
29. Dasari, M.; Espargaro, A.; Sabate, R.; Lopez Del Amo, J.M.; Fink, U.; Grelle, G.; Bieschke, J.; Ventura, S.; Reif, B. Bacterial inclusion bodies of alzheimer's disease beta-amyloid peptides can be employed to study native-like aggregation intermediate states. Chembiochem, 2011, 12(3), 407-423.
30. Espargaro, A.; Sabate, R.; Ventura, S. Kinetic and thermodynamic stability of bacterial intracellular aggregates. FEBS Lett., 2008, 582(25-26), 3669-3673.
31. Sabate, R.; Saupe, S.J. Thioflavin T fluorescence anisotropy: an alternative technique for the study of amyloid aggregation. Biochem. Biophys. Res. Commun., 2007, 360(1), 135-138.
32. Makin, O.S.; Serpell, L.C. X-ray diffraction studies of amyloid structure. Methods Mol. Biol., 2005, 299, 67-80.
33. Kelenyi, G. Thioflavin S fluorescent and Congo red anisotropic stainings in the histologic demonstration of amyloid. Acta. Neuropathol., 1967, 7(4), 336-348.
34. Klunk, W.E.; Debnath, M.L.; Pettegrew, J.W. Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe. Neurobiol. Aging, 1995, 16(4), 541-548.
35. Klunk, W.E.; Jacob, R.F.; Mason, R.P. Quantifying amyloid betapeptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay. Anal. Biochem., 1999, 266(1), 66-76.
36. Mishra, R.; Sjolander, D.; Hammarstrom, P. Spectroscopic characterization of diverse amyloid fibrils in vitro by the fluorescent dye Nile red. Mol. Biosyst., 2011, 7(4), 1232-1240.
37. Naiki, H.; Higuchi, K.; Hosokawa, M.; Takeda, T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal. Biochem., 1989, 177(2), 244-249.
38. Sabate, R.; Estelrich, J. Pinacyanol as effective probe of fibrillar beta-amyloid peptide: comparative study with Congo Red. Biopolymers, 2003, 72(6), 455-463.
39. Stiller, D.; Katenkamp, D.; Thoss, K. Fluorescence histochemistry demonstration of amyloid with thioflavin S and acridine orange. Acta. Histochem., 1970, 38(1), 18-30.
40. Wolman, M.; Bubis, J.J. The cause of the green polarization color of amyloid stained with Congo red. Histochemie, 1965, 4(5), 351-356.
41. Steensma, D.P. Congo red: out of Africa? Arch. Pathol. Lab Med., 2001, 125(2), 250-252.
42. Inouye, H.; Kirschner, D.A. A beta fibrillogenesis: kinetic parameters for fibril formation from congo red binding. J. Struct. Biol., 2000, 130(2-3), 123-129.
43. Inouye, H.; Nguyen, J.T.; Fraser, P.E.; Shinchuk, L.M.; Packard, A.B.; Kirschner, D.A. Histidine residues underlie Congo red binding to A beta analogs. Amyloid 2000, 7(3), 179-188.
44. Klunk, W.E.; Pettegrew, J.W.; Abraham, D.J. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J. Histochem. Cytochem., 1989, 37(8), 1273-1281.
45. Klunk, W.E.; Pettegrew, J.W.; Abraham, D.J. Two simple methods for quantifying low-affinity dye-substrate binding. J. Histochem. Cytochem., 1989, 37(8), 1293-1297.
46. Sabate, R.; Espargaro, A.; Saupe, S.J.; Ventura, S. Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion. Microb. Cell Fact., 2009, 8(56.
47. Schutz, A.K.; Soragni, A.; Hornemann, S.; Aguzzi, A.; Ernst, M.; Bockmann, A.; Meier, B.H. The Amyloid-Congo Red Interface at Atomic Resolution. Angew. Chem. Int. Ed. Engl., 2011, 50(26), 5956-5960.
48. Giorgadze, T.A.; Shiina, N.; Baloch, Z.W.; Tomaszewski, J.E.; Gupta, P.K. Improved detection of amyloid in fat pad aspiration: an evaluation of Congo red stain by fluorescent microscopy. Diagn. Cytopathol., 2004, 31(5), 300-306.
49. Puchtler, H.; Sweat, F. Congo red as a stain for fluorescence microscopy of amyloid. J. Histochem. Cytochem., 1965, 13(8), 693-694.
50. Adams, S.J.; DeTure, M.A.; McBride, M.; Dickson, D.W.; Petrucelli, L. Three repeat isoforms of tau inhibit assembly of four repeat tau filaments. PLoS One, 2010, 5(5), e10810.
51. Biancalana, M.; Koide, S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta., 2010, 1804(7), 1405-1412.
52. Khurana, R.; Coleman, C.; Ionescu-Zanetti, C.; Carter, S.A.; Krishna, V.; Grover, R.K.; Roy, R.; Singh, S. Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol., 2005, 151(3), 229-238.
53. LeVine, H., 3rd Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci., 1993, 2(3), 404-410.
54. LeVine, H., 3rd Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol., 1999, 309 274-284.
55. Naiki, H.; Gejyo, F. Kinetic analysis of amyloid fibril formation. Methods Enzymol., 1999, 309, 305-318.
56. Ban, T.; Hamada, D.; Hasegawa, K.; Naiki, H.; Goto, Y. Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J. Biol. Chem., 2003, 278(19), 16462-16465.
57. Dzwolak, W.; Pecul, M. Chiral bias of amyloid fibrils revealed by the twisted conformation of Thioflavin T: an induced circular dichroism/DFT study. FEBS Lett., 2005, 579(29), 6601-6603.
58. Espargaro, A.; Sabate, R.; Ventura, S. Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation. Mol. Biosyst., 2012, 8(11), 2839-2844.
59. Espargaro, A.; Villar-Pique, A.; Sabate, R.; Ventura, S. Yeast prions form infectious amyloid inclusion bodies in bacteria. Microb. Cell Fact., 2012, 11(1), 89.
60. Sabate, R.; Villar-Pique, A.; Espargaro, A.; Ventura, S. Temperature dependence of the aggregation kinetics of Sup35 and Ure2p yeast prions. Biomacromolecules, 2012, 13(2), 474-483.
61. Hubbard, S.J. The structural aspects of limited proteolysis of native proteins. Biochim. Biophys. Acta., 1998, 1382(2), 191-206.
62. Balguerie, A.; Dos Reis, S.; Coulary-Salin, B.; Chaignepain, S.; Sabourin, M.; Schmitter, J.M.; Saupe, S.J. The sequences appended to the amyloid core region of the HET-s prion protein determine higher-order aggregate organization in vivo. J. Cell Sci., 2004, 117(Pt 12), 2599-2610.
63. Rodriguez, A.; Martin, M.; Albasanz, J.L.; Barrachina, M.; Espinosa, J.C.; Torres, J.M.; Ferrer, I. Group I mGluR signaling in BSE-infected bovine-PrP transgenic mice. Neurosci. Lett., 2006, 410(2), 115-120.
64. Georgescauld, F.; Sabate, R.; Espargaro, A.; Ventura, S.; Chaignepain, S.; Lacombe, M.L.; Lascu, I. Aggregation of the neuroblastoma-associated mutant (S120G) of the human nucleoside diphosphate kinase-A/NM23-H1 into amyloid fibrils. Naunyn. Schmiedebergs Arch. Pharmacol., 2011, 384(4-5), 373-381.
65. Makarava, N.; Kovacs, G.G.; Savtchenko, R.; Alexeeva, I.; Ostapchenko, V.G.; Budka, H.; Rohwer, R.G.; Baskakov, I.V. A new mechanism for transmissible prion diseases. J. Neurosci., 2012, 32(21), 7345-7355.
66. Sabate, R.; Espargaro, A.; Grana-Montes, R.; Reverter, D.; Ventura, S. Native Structure Protects SUMO Proteins from Aggregation into Amyloid Fibrils. Biomacromolecules, 2012, 13(6), 1916-1926.
67. Bagriantsev, S.N.; Kushnirov, V.V.; Liebman, S.W. Analysis of amyloid aggregates using agarose gel electrophoresis. Methods Enzymol., 2006, 412, 33-48.
68. Halfmann, R.; Lindquist, S. Screening for amyloid aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis. J. Vis. Exp., 2008, (17). pii, 838.
69. Alberti, S.; Halfmann, R.; Lindquist, S. Biochemical, cell biological, and genetic assays to analyze amyloid and prion aggregation in yeast. Methods Enzymol., 2010, 470, 709-734.
70. Boye-Harnasch, M.; Cullin, C. A novel in vitro filter trap assay identifies tannic acid as an amyloid aggregation inducer for HET-s. J. Biotechnol., 2006, 125(2), 222-230.
71. Zhang, H.; Xu, L.Q.; Perrett, S. Studying the effects of chaperones on amyloid fibril formation. Methods, 2011, 53(3), 285-294.
72. Collins, S.R.; Douglass, A.; Vale, R.D.; Weissman, J.S. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol., 2004, 2(10), e321.
73. Knowles, T.P.; Waudby, C.A.; Devlin, G.L.; Cohen, S.I.; Aguzzi, A.; Vendruscolo, M.; Terentjev, E.M.; Welland, M.E.; Dobson, C.M. An analytical solution to the kinetics of breakable filament assembly. Science, 2009, 326(5959), 1533-1537.
74. Sabate, R.; Gallardo, M.; Estelrich, J. An autocatalytic reaction as a model for the kinetics of the aggregation of beta-amyloid. Biopolymers, 2003, 71(2), 190-195.
75. Chiti, F.; Dobson, C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem., 2006, 75 333-366.
76. Zurdo, J.; Guijarro, J.I.; Jimenez, J.L.; Saibil, H.R.; Dobson, C.M. Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. J. Mol. Biol., 2001, 311(2), 325-340.
77. Greenfield, N.J. Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc., 2006, 1(6), 2876-2890.
78. Li, C.H.; Nguyen, X.; Narhi, L.; Chemmalil, L.; Towers, E.; Muzammil, S.; Gabrielson, J.; Jiang, Y. Applications of circular dichroism (CD) for structural analysis of proteins: qualification of near- and far-UV CD for protein higher order structural analysis. J. Pharm. Sci., 2011, 100(11), 4642-4654.
79. Hiramatsu, H.; Kitagawa, T. FT-IR approaches on amyloid fibril structure. Biochim. Biophys. Acta., 2005, 1753(1), 100-107.
80. Zandomeneghi, G.; Krebs, M.R.; McCammon, M.G.; Fandrich, M. FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils. Protein Sci.,2004, 13(12), 3314-3321.
81. Belbachir, K.; Lecomte, S.; Ta, H.P.; Petibois, C.; Desbat, B. Orientation of molecular groups of fibers in nonoriented samples determined by polarized ATR-FTIR spectroscopy. Anal. Bioanal. Chem., 2011, 401(10), 3263-3268.
82. Sen, A.; Baxa, U.; Simon, M.N.; Wall, J.S.; Sabate, R.; Saupe, S.J.; Steven, A.C. Mass analysis by scanning transmission electron microscopy and electron diffraction validate predictions of stacked beta-solenoid model of HET-s prion fibrils. J. Biol. Chem.,2007, 282(8), 5545-5550.
83. Sunde, M.; Serpell, L.C.; Bartlam, M.; Fraser, P.E.; Pepys, M.B.; Blake, C.C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol., 1997, 273(3), 729-739.
84. de Groot, N.S.; Parella, T.; Aviles, F.X.; Vendrell, J.; Ventura, S. Ile-phe dipeptide self-assembly: clues to amyloid formation. Biophys. J., 2007, 92(5), 1732-1741.
85. Norlin, N.; Hellberg, M.; Filippov, A.; Sousa, A.A.; Grobner, G.; Leapman, R.D.; Almqvist, N.; Antzutkin, O.N. Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Abeta peptide by CD, TEM, STEM and in situ AFM. J. Struct. Biol., 2012, 180(1), 174-189.
86. Ta, H.P.; Berthelot, K.; Coulary-Salin, B.; Castano, S.; Desbat, B.; Bonnafous, P.; Lambert, O.; Alves, I.; Cullin, C.; Lecomte, S. A yeast toxic mutant of HET-s amyloid disrupts membrane integrity. Biochim. Biophys. Acta., 2012, 1818(9), 2325-2334.
87. Goldsbury, C.; Baxa, U.; Simon, M.N.; Steven, A.C.; Engel, A.; Wall, J.S.; Aebi, U.; Muller, S.A. Amyloid structure and assembly: insights from scanning transmission electron microscopy. J. Struct. Biol., 2011, 173(1), 1-13.
88. Ban, T.; Yamaguchi, K.; Goto, Y. Direct observation of amyloid fibril growth, propagation, and adaptation. Acc. Chem. Res., 2006, 39(9), 663-670.
89. Khurana, R.; Ionescu-Zanetti, C.; Pope, M.; Li, J.; Nielson, L.; Ramirez-Alvarado, M.; Regan, L.; Fink, A.L.; Carter, S.A. A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. Biophys. J., 2003, 85(2), 1135-1144.
90. Pires, R.H.; Karsai, A.; Saraiva, M.J.; Damas, A.M.; Kellermayer, M.S. Distinct Annular Oligomers Captured along the Assembly and Disassembly Pathways of Transthyretin Amyloid Protofibrils. PLoS One, 2012, 7(9), e44992.
91. Knowles, T.P.; Fitzpatrick, A.W.; Meehan, S.; Mott, H.R.; Vendruscolo, M.; Dobson, C.M.; Welland, M.E. Role of intermolecular forces in defining material properties of protein nanofibrils. Science, 2007, 318(5858), 1900-1903.
92. Villar-Pique, A.; de Groot, N.S.; Sabate, R.; Acebron, S.P.; Celaya, G.; Fernandez-Busquets, X.; Muga, A.; Ventura, S. The effect of amyloidogenic peptides on bacterial aging correlates with their intrinsic aggregation propensity. J. Mol. Biol., 2012, 421(2-3), 270-281.
93. Kheterpal, I.; Zhou, S.; Cook, K.D.; Wetzel, R. Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange. Proc. Natl. Acad. Sci. U S A., 2000, 97(25), 13597-13601.
94. Nazabal, A.; Dos Reis, S.; Bonneu, M.; Saupe, S.J.; Schmitter, J.M. Conformational transition occurring upon amyloid aggregation of the HET-s prion protein of Podospora anserina analyzed by hydrogen/deuterium exchange and mass spectrometry. Biochemistry, 2003, 42(29), 8852-8861.
95. Morgan, G.J.; Giannini, S.; Hounslow, A.M.; Craven, C.J.; Zerovnik, E.; Turk, V.; Waltho, J.P.; Staniforth, R.A. Exclusion of the native alpha-helix from the amyloid fibrils of a mixed alpha/beta protein. J. Mol. Biol., 2008, 375(2), 487-498.
96. Hubbell, W.L.; Cafiso, D.S.; Altenbach, C. Identifying conformational changes with site-directed spin labeling. Nat. Struct. Biol., 2000, 7(9), 735-739.
97. Margittai, M.; Langen, R. Spin labeling analysis of amyloids and other protein aggregates. Methods Enzymol., 2006, 413, 122-139.
98. Margittai, M.; Langen, R. Side chain-dependent stacking modulates tau filament structure. J. Biol. Chem., 2006, 281(49), 37820-37827.
99. Strancar, J.; Kavalenka, A.; Urbancic, I.; Ljubetic, A.; Hemminga, M.A. SDSL-ESR-based protein structure characterization. Eur. Biophys. J., 2010, 39(4), 499-511.
100. Krishnan, R.; Lindquist, S.L. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature, 2005, 435(7043), 765-772.
101. Ritter, C.; Maddelein, M.L.; Siemer, A.B.; Luhrs, T.; Ernst, M.; Meier, B.H.; Saupe, S.J.; Riek, R. Correlation of structural elements and infectivity of the HET-s prion. Nature, 2005, 435(7043), 844-848.
102. Tycko, R. Molecular structure of amyloid fibrils: insights from solid-state NMR. Q. Rev. Biophys., 2006, 39(1), 1-55.
103. Tycko, R. Solid-state NMR studies of amyloid fibril structure. Annu. Rev. Phys. Chem., 2011, 62, 279-299.
104. Wasmer, C.; Lange, A.; Van Melckebeke, H.; Siemer, A.B.; Riek, R.; Meier, B.H. Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core. Science, 2008, 319(5869), 1523-1526.
105. Sawaya, M.R.; Sambashivan, S.; Nelson, R.; Ivanova, M.I.; Sievers, S.A.; Apostol, M.I.; Thompson, M.J.; Balbirnie, M.; Wiltzius, J.J.; McFarlane, H.T.; Madsen, A.O.; Riekel, C.; Eisenberg, D. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature, 2007, 447(7143), 453-457.
106. Morell, M.; Espargaro, A.; Aviles, F.X.; Ventura, S. Detection of transient protein-protein interactions by bimolecular fluorescence complementation: the Abl-SH3 case. Proteomics, 2007, 7(7), 1023-1036.
107. Morell, M.; de Groot, N.S.; Vendrell, J.; Aviles, F.X.; Ventura, S. Linking amyloid protein aggregation and yeast survival. Mol. Biosyst., 2011, 7(4), 1121-1128.
108. Serio, T.R.; Lindquist, S.L. Protein-only inheritance in yeast: something to get [PSI+]-ched about. Trends Cell Biol., 2000, 10(3), 98-105.
109. Sabate, R.; Espargaro, A.; Barbosa-Barros, L.; Ventura, S.; Estelrich, J. Effect of the surface charge of artificial model membranes on the aggregation of amyloid beta-peptide. Biochimie., 2012, 94(8), 1730-1738.
110. Ventura, S.; Villaverde, A. Protein quality in bacterial inclusion bodies. Trends Biotechnol., 2006, 24(4), 179-185.
111. Wang, L. Towards revealing the structure of bacterial inclusion bodies. Prion., 2009, 3(3), 139-145.
112. Wang, L.; Maji, S.K.; Sawaya, M.R.; Eisenberg, D.; Riek, R. Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol., 2008, 6(8), e195.
113. Wasmer, C.; Benkemoun, L.; Sabate, R.; Steinmetz, M.O.; Coulary-Salin, B.; Wang, L.; Riek, R.; Saupe, S.J.; Meier, B.H. Solid-State NMR Spectroscopy Reveals that E. coli Inclusion Bodies of HET-s(218-289) are Amyloids. Angew. Chem. Int. Ed. Engl., 2009, 48(26), 4858-4860.
114. Garcia-Fruitos, E.; Sabate, R.; de Groot, N.S.; Villaverde, A.; Ventura, S. Biological role of bacterial inclusion bodies: a model for amyloid aggregation. FEBS J., 2011, 278(14), 2419-2427.
115. Darghal, N.; Garnier-Suillerot, A.; Salerno, M. Mechanism of thioflavin T accumulation inside cells overexpressing Pglycoprotein or multidrug resistance-associated protein: role of lipophilicity and positive charge. Biochem. Biophys. Res. Commun., 2006, 343(2), 623-629.
116. Fowler, D.M.; Koulov, A.V.; Alory-Jost, C.; Marks, M.S.; Balch, W.E.; Kelly, J.W. Functional amyloid formation within mammalian tissue. PLoS Biol., 2006, 4(1), e6.
117. Lee, H.J.; Lee, S.J. Characterization of cytoplasmic alphasynuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J. Biol. Chem., 2002, 277(50), 48976-48983.
118. Urbanc, B.; Cruz, L.; Le, R.; Sanders, J.; Ashe, K.H.; Duff, K.; Stanley, H.E.; Irizarry, M.C.; Hyman, B.T. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc. Natl. Acad. Sci. U S A., 2002, 99(22), 13990-13995.
119. Tsien, R.Y. The green fluorescent protein. Annu. Rev. Biochem., 1998, 67, 509-544.
120. Waldo, G.S.; Standish, B.M.; Berendzen, J.; Terwilliger, T.C. Rapid protein-folding assay using green fluorescent protein. Nat. Biotechnol., 1999, 17(7), 691-695.
121. de Groot, N.S.; Ventura, S. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates. J. Biotechnol., 2006, 125(1), 110-113.
122. Kim, W.; Hecht, M.H. Mutations enhance the aggregation propensity of the Alzheimer's A beta peptide. J. Mol. Biol., 2008, 377(2), 565-574.
123. Lee, L.L.; Ha, H.; Chang, Y.T.; DeLisa, M.P. Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility. Protein Sci., 2009, 18(2), 277-286.
124. Fernandez-Tresguerres, M.E.; de la Espina, S.M.; Gasset-Rosa, F.; Giraldo, R. A DNA-promoted amyloid proteinopathy in Escherichia coli. Mol. Microbiol., 2010, 77(6), 1456-1469.
125. Tsien, R.Y. Constructing and exploiting the fluorescent protein paintbox (Nobel Lecture). Angew. Chem. Int. Ed. Engl., 2009, 48(31), 5612-5626.
126. Outeiro, T.F.; Klucken, J.; Bercury, K.; Tetzlaff, J.; Putcha, P.; Oliveira, L.M.; Quintas, A.; McLean, P.J.; Hyman, B.T. Dopamine-induced conformational changes in alpha-synuclein. PLoS One, 2009, 4(9), e6906.
127. Kaminski Schierle, G.S.; Bertoncini, C.W.; Chan, F.T.; van der Goot, A.T.; Schwedler, S.; Skepper, J.; Schlachter, S.; van Ham, T.; Esposito, A.; Kumita, J.R.; Nollen, E.A.; Dobson, C.M.; Kaminski, C.F. A FRET sensor for non-invasive imaging of amyloid formation in vivo. Chemphyschem., 2011, 12(3), 673-680.
128. Roberti, M.J.; Bertoncini, C.W.; Klement, R.; Jares-Erijman, E.A.; Jovin, T.M. Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein. Nat. Methods, 2007, 4(4), 345-351.
129. Kerppola, T.K. Bimolecular fluorescence complementation: visualization of molecular interactions in living cells. Methods Cell Biol., 2008, 85 431-470.
130. Goncalves, S.A.; Matos, J.E.; Outeiro, T.F. Zooming into protein oligomerization in neurodegeneration using BiFC. Trends Biochem. Sci., 2010, 35(11), 643-651.
131. Herrera, F.; Goncalves, S.; Outeiro, T.F. Imaging protein oligomerization in neurodegeneration using bimolecular fluorescence complementation. Methods Enzymol., 2012, 506, 157-174.
132. Outeiro, T.F.; Muchowski, P.J. Molecular genetics approaches in yeast to study amyloid diseases. J. Mol. Neurosci., 2004, 23(1-2), 49-60.
133. Pereira, C.; Bessa, C.; Soares, J.; Leao, M.; Saraiva, L. Contribution of yeast models to neurodegeneration research. J. Biomed. Biotechnol., 2012, 2012, 941232.
134. Summers, D.W.; Cyr, D.M. Use of yeast as a system to study amyloid toxicity. Methods, 2011, 53(3), 226-231.
135. Tenreiro, S.; Outeiro, T.F. Simple is good: yeast models of neurodegeneration. FEMS Yeast Res., 2010, 10(8), 970-979.
136. Treusch, S.; Hamamichi, S.; Goodman, J.L.; Matlack, K.E.; Chung, C.Y.; Baru, V.; Shulman, J.M.; Parrado, A.; Bevis, B.J.; Valastyan, J.S.; Han, H.; Lindhagen-Persson, M.; Reiman, E.M.; Evans, D.A.; Bennett, D.A.; Olofsson, A.; DeJager, P.L.; Tanzi, R.E.; Caldwell, K.A.; Caldwell, G.A.; Lindquist, S. Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science, 2011, 334(6060), 1241-1245.
137. Prusiner, S.B. Shattuck lecture--neurodegenerative diseases and prions. N. Engl. J. Med., 2001, 344(20), 1516-1526.
138. Coustou, V.; Deleu, C.; Saupe, S.; Begueret, J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl. Acad. Sci. U S A., 1997, 94(18), 9773-9778.
139. Halfmann, R.; Jarosz, D.F.; Jones, S.K.; Chang, A.; Lancaster, A.K.; Lindquist, S. Prions are a common mechanism for phenotypic inheritance in wild yeasts. Nature, 2012, 482(7385), 363-368.
140. Wickner, R.B.; Edskes, H.K.; Shewmaker, F.; Nakayashiki, T. Prions of fungi: inherited structures and biological roles. Nat. Rev. Microbiol., 2007, 5(8), 611-618.
141. Chien, P.; Weissman, J.S.; DePace, A.H. Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem., 2004, 73, 617-656.
142. Bagriantsev, S.; Liebman, S. Modulation of Abeta42 low-n oligomerization using a novel yeast reporter system. BMC Biol., 2006, 4, 32.
143. Serio, T.R.; Lindquist, S.L. [PSI+]: an epigenetic modulator of translation termination efficiency. Annu. Rev. Cell Dev. Biol., 1999, 15, 661-703.
144. Alberti, S.; Halfmann, R.; King, O.; Kapila, A.; Lindquist, S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell, 2009, 137(1), 146-158.
145. Stewart, C.N., Jr. Go with the glow: fluorescent proteins to light transgenic organisms. Trends Biotechnol., 2006, 24(4), 155-162.
146. Rajamohamedsait, H.B.; Sigurdsson, E.M. Histological staining of amyloid and pre-amyloid peptides and proteins in mouse tissue. Methods Mol. Biol., 2012, 849, 411-424.
147. van Dooren, T.; Dewachter, I.; Borghgraef, P.; van Leuven, F. Transgenic mouse models for APP processing and Alzheimer's disease: early and late defects. Subcell. Biochem., 2005, 38, 45-63.
148. van Ham, T.J.; Breitling, R.; Swertz, M.A.; Nollen, E.A. Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms. EMBO Mol. Med., 2009, 1(8-9), 360-370.
149. Kopito, R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol., 2000, 10(12), 524-530.
150. Palazzolo, I.; Nedelsky, N.B.; Askew, C.E.; Harmison, G.G.; Kasantsev, A.G.; Taylor, J.P.; Fischbeck, K.H.; Pennuto, M. B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy. J. Neurosci. Res., 2010, 88(10), 2207-2216.
151. Nedelsky, N.B.; Todd, P.K.; Taylor, J.P. Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. Biochim. Biophys. Acta., 2008, 1782(12), 691-699.
152. Invernizzi, G.; Papaleo, E.; Sabate, R.; Ventura, S. Protein aggregation: mechanisms and functional consequences. Int. J. Biochem. Cell Biol., 2012, 44(9), 1541-1554.
153. Kodali, R.; Wetzel, R. Polymorphism in the intermediates and products of amyloid assembly. Curr. Opin. Struct. Biol., 2007, 17(1), 48-57.
154. Sabate, R.; Gallardo, M.; Estelrich, J. Spontaneous incorporation of beta-amyloid peptide into neutral liposomes. Colloids and Surfaces A., 2005, 270-271, 13-17.
155. Bucciantini, M.; Nosi, D.; Forzan, M.; Russo, E.; Calamai, M.; Pieri, L.; Formigli, L.; Quercioli, F.; Soria, S.; Pavone, F.; Savistchenko, J.; Melki, R.; Stefani, M. Toxic effects of amyloid fibrils on cell membranes: the importance of ganglioside GM1. FASEB J., 2012, 26(2), 818-831.
156. Cecchi, C.; Stefani, M. The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity. Biophys. Chem., 2013, 182, 30-43.
157. Alberdi, E.; Wyssenbach, A.; Alberdi, M.; Sanchez-Gomez, M.V.; Cavaliere, F.; Rodriguez, J.J.; Verkhratsky, A.; Matute, C. Ca(2+) - dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid beta-treated astrocytes and in a model of Alzheimer's disease. Aging Cell, 2013, 12(2), 292-302.
158. Cuanalo-Contreras, K.; Mukherjee, A.; Soto, C. Role of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and Aging. Int. J. Cell Biol., 2013, 2013, 638083.
159. Park, J.; Jang, M.; Chang, S. Deleterious effects of soluble amyloid-beta oligomers on multiple steps of synaptic vesicle trafficking. Neurobiol. Dis., 2013, 55, 129-139.
160. Nishitsuji, K.; Tomiyama, T.; Ishibashi, K.; Ito, K.; Teraoka, R.; Lambert, M.P.; Klein, W.L.; Mori, H. The E693Delta mutation in amyloid precursor protein increases intracellular accumulation of amyloid beta oligomers and causes endoplasmic reticulum stressinduced apoptosis in cultured cells. Am. J. Pathol., 2009, 174(3), 957-969.
161. Meratan, A.A.; Ghasemi, A.; Nemat-Gorgani, M. Membrane integrity and amyloid cytotoxicity: a model study involving mitochondria and lysozyme fibrillation products. J. Mol. Biol., 2011, 409(5), 826-838.
162. Bucciantini, M.; Rigacci, S.; Berti, A.; Pieri, L.; Cecchi, C.; Nosi, D.; Formigli, L.; Chiti, F.; Stefani, M. Patterns of cell death triggered in two different cell lines by HypF-N prefibrillar aggregates. FASEB J., 2005, 19(3), 437-439.
163. Jelinek, R.; Sheynis, T. Amyloid - membrane interactions: experimental approaches and techniques. Curr. Protein Pept. Sci., 2010, 11(5), 372-384.
164. Lahdo, R.; Coillet-Matillon, S.; Chauvet, J.P.; de La Fourniere-Bessueille, L. The amyloid precursor protein interacts with neutral lipids. Eur. J. Biochem., 2002, 269(8), 2238-2246.
165. Maget-Dana, R. The monolayer technique: a potent tool for studying the interfacial properties of antimicrobial and membranelytic peptides and their interactions with lipid membranes. Biochim. Biophys. Acta., 1999, 1462(1-2), 109-140.
166. Thakur, G.; Micic, M.; Leblanc, R.M. Surface chemistry of Alzheimer's disease: a Langmuir monolayer approach. Colloids Surf. B Biointerfaces, 2009, 74(2), 436-456.
167. Askarova, S.; Yang, X.; Lee, J.C. Impacts of membrane biophysics in Alzheimer's disease: from amyloid precursor protein processing to abeta Peptide-induced membrane changes. Int. J. Alzheimers Dis., 2011, 2011, 134971.
168. Jo, E.; Darabie, A.A.; Han, K.; Tandon, A.; Fraser, P.E.; McLaurin, J. alpha-Synuclein-synaptosomal membrane interactions: implications for fibrillogenesis. Eur. J. Biochem., 2004, 271(15), 3180-3189.
169. Knight, J.D.; Williamson, J.A.; Miranker, A.D. Interaction of membrane-bound islet amyloid polypeptide with soluble and crystalline insulin. Protein Sci., 2008, 17(10), 1850-1856.
170. Relini, A.; Torrassa, S.; Rolandi, R.; Gliozzi, A.; Rosano, C.; Canale, C.; Bolognesi, M.; Plakoutsi, G.; Bucciantini, M.; Chiti, F.; Stefani, M. Monitoring the process of HypF fibrillization and liposome permeabilization by protofibrils. J. Mol. Biol., 2004, 338(5), 943-957.
171. Xue, W.F.; Hellewell, A.L.; Hewitt, E.W.; Radford, S.E. Fibril fragmentation in amyloid assembly and cytotoxicity: when size matters. Prion., 2010, 4(1), 20-25.
172. Mingeot-Leclercq, M.P.; Lins, L.; Bensliman, M.; Van Bambeke, F.; Van Der Smissen, P.; Peuvot, J.; Schanck, A.; Brasseur, R. Membrane destabilization induced by beta-amyloid peptide 29-42: importance of the amino-terminus. Chem. Phys. Lipids, 2002, 120(1-2), 57-74.
173. Kremer, J.J.; Murphy, R.M. Kinetics of adsorption of beta-amyloid peptide Abeta(1-40) to lipid bilayers. J. Biochem. Biophys. Methods, 2003, 57(2), 159-169.
174. Yip, C.M.; McLaurin, J. Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys. J., 2001, 80(3), 1359-1371.
175. Lin, H.; Bhatia, R.; Lal, R. Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J., 2001, 15(13), 2433-2444.
176. Parasassi, T.; Di Stefano, M.; Ravagnan, G.; Sapora, O.; Gratton, E. Membrane aging during cell growth ascertained by Laurdan generalized polarization. Exp. Cell Res., 1992, 202(2), 432-439.
177. Parasassi, T.; Gratton, E.; Yu, W.M.; Wilson, P.; Levi, M. Twophoton fluorescence microscopy of laurdan generalized polarization domains in model and natural membranes. Biophys. J., 1997, 72(6), 2413-2429.
178. Sparr, E.; Engel, M.F.; Sakharov, D.V.; Sprong, M.; Jacobs, J.; de Kruijff, B.; Hoppener, J.W.; Killian, J.A. Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett., 2004, 577(1-2), 117-120.
179. van Rooijen, B.D.; Claessens, M.M.; Subramaniam, V. Membrane Permeabilization by Oligomeric alpha-Synuclein: In Search of the Mechanism. PLoS One, 2010, 5(12), e14292.
180. Kurganov, B.; Doh, M.; Arispe, N. Aggregation of liposomes induced by the toxic peptides Alzheimer's Abetas, human amylin and prion (106-126): facilitation by membrane-bound GM1 ganglioside. Peptides, 2004, 25(2), 217-232.
181. Kremer, J.J.; Pallitto, M.M.; Sklansky, D.J.; Murphy, R.M. Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry, 2000, 39(33), 10309-10318.
182. Bharadwaj, P.; Waddington, L.; Varghese, J.; Macreadie, I.G. A new method to measure cellular toxicity of non-fibrillar and fibrillar Alzheimer's Abeta using yeast. J. Alzheimers Dis., 2008, 13(2), 147-150.
183. D'Angelo, F.; Vignaud, H.; Di Martino, J.; Salin, B.; Devin, A.; Cullin, C.; Marchal, C. A yeast model for amyloid-beta aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity. Dis. Model Mech., 2013, 6(1), 206-216.
184. Zhao, X.; Park, Y.N.; Todor, H.; Moomau, C.; Masison, D.; Eisenberg, E.; Greene, L.E. Sequestration of Sup35 by aggregates of huntingtin fragments causes toxicity of [PSI+] yeast. J. Biol. Chem., 2012, 287(28), 23346-23355.
185. Datki, Z.; Juhasz, A.; Galfi, M.; Soos, K.; Papp, R.; Zadori, D.; Penke, B. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res. Bull., 2003, 62(3), 223-229.
186. Mozes, E.; Hunya, A.; Posa, A.; Penke, B.; Datki, Z. A novel method for the rapid determination of beta-amyloid toxicity on acute hippocampal slices using MTT and LDH assays. Brain Res. Bull., 2012, 87(6), 521-525.
187. Ronicke, R.; Klemm, A.; Meinhardt, J.; Schroder, U.H.; Fandrich, M.; Reymann, K.G. Abeta mediated diminution of MTT reduction- -an artefact of single cell culture? PLoS One, 2008, 3(9), e3236.
188. Wogulis, M.; Wright, S.; Cunningham, D.; Chilcote, T.; Powell, K.; Rydel, R.E. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J. Neurosci., 2005, 25(5), 1071-1080.
189. Decker, T.; Lohmann-Matthes, M.L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods, 1988, 115(1), 61-69.